Cargando…
Chimeric RNA-binding protein-based killing switch targeting hepatocellular carcinoma cells
Cancer cell-specific killing switches are synthetic circuits developed as an intelligent weapon to specifically eliminate malignant cells. RNA-delivered synthetic circuits provide safer means to control oncolytic functions, in which proteolysis-responding capsid-cNOT7 is developed to enable logic co...
Autores principales: | Yang, Jiong, Ding, Shigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463442/ https://www.ncbi.nlm.nih.gov/pubmed/34589286 http://dx.doi.org/10.1016/j.omtn.2021.08.012 |
Ejemplares similares
-
Synthetic switch-based baculovirus for transgene expression control and selective killing of hepatocellular carcinoma cells
por: Lin, Mei-Wei, et al.
Publicado: (2018) -
Programmable Synthetic Protein Circuits for the Identification and Suppression of Hepatocellular Carcinoma
por: Han, Xu, et al.
Publicado: (2020) -
Optimization of GPC3-specific chimeric antigen receptor structure and its effect on killing hepatocellular carcinoma cells
por: Zhao, Jianfeng, et al.
Publicado: (2021) -
Membrane protein-chimeric liposome-mediated delivery of triptolide for targeted hepatocellular carcinoma therapy
por: Zheng, Yanwen, et al.
Publicado: (2021) -
Adenanthin targets peroxiredoxin I/II to kill hepatocellular carcinoma cells
por: Hou, J-K, et al.
Publicado: (2014)